These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

126 related articles for article (PubMed ID: 15133757)

  • 1. Improved insulin secretory function and reduced chemotactic properties after tissue culture of islets from type 1 diabetic patients.
    Lupi R; Marselli L; Dionisi S; Del Guerra S; Boggi U; Del Chiaro M; Lencioni C; Bugliani M; Mosca F; Di Mario U; Del Prato S; Dotta F; Marchetti P
    Diabetes Metab Res Rev; 2004; 20(3):246-51. PubMed ID: 15133757
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Human pancreatic islet function at the onset of type 1 (insulin-dependent) diabetes mellitus.
    Conget I; Fernández-Alvarez J; Ferrer J; Sarri Y; Novials A; Somoza N; Pujol-Borrell R; Casamitjana R; Gomis R
    Diabetologia; 1993 Apr; 36(4):358-60. PubMed ID: 8477882
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Expression of glucose transporter-2, glucokinase and mitochondrial glycerolphosphate dehydrogenase in pancreatic islets during rat ontogenesis.
    García-Flores M; Zueco JA; Arenas J; Blázquez E
    Eur J Biochem; 2002 Jan; 269(1):119-27. PubMed ID: 11784305
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Reversal of beta-cell suppression in vitro in pancreatic islets isolated from nonobese diabetic mice during the phase preceding insulin-dependent diabetes mellitus.
    Strandell E; Eizirik DL; Sandler S
    J Clin Invest; 1990 Jun; 85(6):1944-50. PubMed ID: 2189896
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Differential sensitivity to beta-cell secretagogues in cultured rat pancreatic islets exposed to human interleukin-1 beta.
    Eizirik DL; Sandler S; Hallberg A; Bendtzen K; Sener A; Malaisse WJ
    Endocrinology; 1989 Aug; 125(2):752-9. PubMed ID: 2666106
    [TBL] [Abstract][Full Text] [Related]  

  • 6. High glucose-induced impairment in insulin secretion is associated with reduction in islet glucokinase in a mouse model of susceptibility to islet dysfunction.
    Kooptiwut S; Kebede M; Zraika S; Visinoni S; Aston-Mourney K; Favaloro J; Tikellis C; Thomas MC; Forbes JM; Cooper ME; Dunlop M; Proietto J; Andrikopoulos S
    J Mol Endocrinol; 2005 Aug; 35(1):39-48. PubMed ID: 16087720
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Functional and molecular defects of pancreatic islets in human type 2 diabetes.
    Del Guerra S; Lupi R; Marselli L; Masini M; Bugliani M; Sbrana S; Torri S; Pollera M; Boggi U; Mosca F; Del Prato S; Marchetti P
    Diabetes; 2005 Mar; 54(3):727-35. PubMed ID: 15734849
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Inhibitory effects of streptozotocin, tumor necrosis factor-alpha, and interleukin-1beta on glucokinase activity in pancreatic islets and gene expression of GLUT2 and glucokinase.
    Park C; Kim JR; Shim JK; Kang BS; Park YG; Nam KS; Lee YC; Kim CH
    Arch Biochem Biophys; 1999 Feb; 362(2):217-24. PubMed ID: 9989930
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Interleukin-18 mRNA, but not interleukin-18 receptor mRNA, is constitutively expressed in islet beta-cells and up-regulated by interferon-gamma.
    Hong TP; Andersen NA; Nielsen K; Karlsen AE; Fantuzzi G; Eizirik DL; Dinarello CA; Mandrup-Poulsen T
    Eur Cytokine Netw; 2000 Jun; 11(2):193-205. PubMed ID: 10903798
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Overexpression of mitochondrial FAD-linked glycerol-3-phosphate dehydrogenase does not correct glucose-stimulated insulin secretion from diabetic GK rat pancreatic islets.
    Ueda K; Tanizawa Y; Ishihara H; Kizuki N; Ohta Y; Matsutani A; Oka Y
    Diabetologia; 1998 Jun; 41(6):649-53. PubMed ID: 9662045
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Functional and morphological alterations of mitochondria in pancreatic beta cells from type 2 diabetic patients.
    Anello M; Lupi R; Spampinato D; Piro S; Masini M; Boggi U; Del Prato S; Rabuazzo AM; Purrello F; Marchetti P
    Diabetologia; 2005 Feb; 48(2):282-9. PubMed ID: 15654602
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Inhibitory effects of interleukin 1 on insulin secretion, insulin biosynthesis, and oxidative metabolism of isolated rat pancreatic islets.
    Sandler S; Andersson A; Hellerström C
    Endocrinology; 1987 Oct; 121(4):1424-31. PubMed ID: 3308437
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Glucosamine-induced beta-cell dysfunction: a possible involvement of glucokinase or glucose-transporter type 2.
    Yoshikawa H; Tajiri Y; Sako Y; Hashimato T; Umeda F; Nawata H
    Pancreas; 2002 Apr; 24(3):228-34. PubMed ID: 11893929
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Enzymatic, metabolic and secretory patterns in human islets of type 2 (non-insulin-dependent) diabetic patients.
    Fernandez-Alvarez J; Conget I; Rasschaert J; Sener A; Gomis R; Malaisse WJ
    Diabetologia; 1994 Feb; 37(2):177-81. PubMed ID: 8163052
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Tissue factor/factor VIIa signalling promotes cytokine-induced beta cell death and impairs glucose-stimulated insulin secretion from human pancreatic islets.
    Edén D; Siegbahn A; Mokhtari D
    Diabetologia; 2015 Nov; 58(11):2563-72. PubMed ID: 26271343
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Deficiency of pyruvate dehydrogenase activity in pancreatic islets of diabetic GK rats.
    Zhou YP; Ostenson CG; Ling ZC; Grill V
    Endocrinology; 1995 Aug; 136(8):3546-51. PubMed ID: 7628391
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cytokines suppress human islet function irrespective of their effects on nitric oxide generation.
    Eizirik DL; Sandler S; Welsh N; Cetkovic-Cvrlje M; Nieman A; Geller DA; Pipeleers DG; Bendtzen K; Hellerström C
    J Clin Invest; 1994 May; 93(5):1968-74. PubMed ID: 7514190
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Upregulation of HLA class II in pancreatic beta cells from organ donors with type 1 diabetes.
    Quesada-Masachs E; Zilberman S; Rajendran S; Chu T; McArdle S; Kiosses WB; Lee JM; Yesildag B; Benkahla MA; Pawlowska A; Graef M; Pfeiffer S; Mikulski Z; von Herrath M
    Diabetologia; 2022 Feb; 65(2):387-401. PubMed ID: 34932134
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Dexamethasone-induced changes in FAD-glycerophosphate dehydrogenase mRNA, content and activity, and insulin release in human pancreatic islets.
    Fabregat ME; Fernandez-Alvarez J; Franco C; Malaisse WJ; Gomis R
    Diabetes Nutr Metab; 1999 Dec; 12(6):388-93. PubMed ID: 10782559
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Interleukin-6 affects insulin secretion and glucose metabolism of rat pancreatic islets in vitro.
    Sandler S; Bendtzen K; Eizirik DL; Welsh M
    Endocrinology; 1990 Feb; 126(2):1288-94. PubMed ID: 2404746
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.